These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29916734)

  • 1. Polymeric, injectable, intravitreal hydrogel devices for posterior segment applications and interventions.
    Anwary M; Kumar P; du Toit LC; Choonara YE; Pillay V
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1074-1081. PubMed ID: 29916734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ antibody-loaded hydrogel for intravitreal delivery.
    Awwad S; Abubakre A; Angkawinitwong U; Khaw PT; Brocchini S
    Eur J Pharm Sci; 2019 Sep; 137():104993. PubMed ID: 31302214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel.
    Zhang L; Shen W; Luan J; Yang D; Wei G; Yu L; Lu W; Ding J
    Acta Biomater; 2015 Sep; 23():271-281. PubMed ID: 26004219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotherapy for posterior eye diseases.
    Kaur IP; Kakkar S
    J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System.
    Osswald CR; Kang-Mieler JJ
    Curr Eye Res; 2016 Sep; 41(9):1216-22. PubMed ID: 26764892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable biodegradable hydrogels from vitamin D-functionalized polycarbonates for the delivery of avastin with enhanced therapeutic efficiency against metastatic colorectal cancer.
    Lee AL; Ng VW; Gao S; Hedrick JL; Yang YY
    Biomacromolecules; 2015 Feb; 16(2):465-75. PubMed ID: 25543531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
    Bisht R; Jaiswal JK; Rupenthal ID
    Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System.
    Osswald CR; Guthrie MJ; Avila A; Valio JA; Mieler WF; Kang-Mieler JJ
    Curr Eye Res; 2017 Sep; 42(9):1293-1301. PubMed ID: 28557571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Characteristics and Potential Application of Poly(β-Amino Ester Urethane)-Based Multiblock Co-Polymers as an Injectable, Biodegradable and pH/Temperature-Sensitive Hydrogel System.
    Huynh CT; Nguyen MK; Jeong IK; Kim SW; Lee DS
    J Biomater Sci Polym Ed; 2012; 23(8):1091-106. PubMed ID: 21619729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomineralized biomimetic organic/inorganic hybrid hydrogels based on hyaluronic acid and poloxamer.
    Huh HW; Zhao L; Kim SY
    Carbohydr Polym; 2015 Aug; 126():130-40. PubMed ID: 25933531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable Microspheres as Intravitreal Delivery Systems for Prolonged Drug Release. What is their Eminence in the Nanoparticle Era?
    Gavini E; Bonferoni MC; Rassu G; Obinu A; Ferrari F; Giunchedi P
    Curr Drug Deliv; 2018; 15(7):930-940. PubMed ID: 29484995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermosensitive polymeric hydrogels as drug delivery systems.
    Gong C; Qi T; Wei X; Qu Y; Wu Q; Luo F; Qian Z
    Curr Med Chem; 2013; 20(1):79-94. PubMed ID: 23092130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of Avastin® from polysaccharides cross-linked hydrogels for ocular drug delivery.
    Xu X; Weng Y; Xu L; Chen H
    Int J Biol Macromol; 2013 Sep; 60():272-6. PubMed ID: 23748006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled and Extended Release of a Model Protein from a Microsphere-Hydrogel Drug Delivery System.
    Osswald CR; Kang-Mieler JJ
    Ann Biomed Eng; 2015 Nov; 43(11):2609-17. PubMed ID: 25835212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogel Ring for Topical Drug Delivery to the Ocular Posterior Segment.
    Shikamura Y; Yamazaki Y; Matsunaga T; Sato T; Ohtori A; Tojo K
    Curr Eye Res; 2016 May; 41(5):653-61. PubMed ID: 26237665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal hydrogels for sustained release of therapeutic proteins.
    Ilochonwu BC; Urtti A; Hennink WE; Vermonden T
    J Control Release; 2020 Oct; 326():419-441. PubMed ID: 32717302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications.
    Alexander A; Ajazuddin ; Khan J; Saraf S; Saraf S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):575-85. PubMed ID: 25092423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.